Seattle Genetics Inc (SGEN)

SGEN (NASDAQ:Drugs)
$39.35
neg -1.25
-3.08%
Today's Range: 39.20 - 40.52 | SGEN Avg Daily Volume: 927,000
Last Update: 09/22/14 - 2:01 PM EDT
Volume: 694,521
YTD Performance: 1.78%
Open: $40.50
Previous Close: $40.60
52 Week Range: $32.35 - $55.99
Oustanding Shares: 123,447,871
Market Cap: 5,079,879,892
6-Month Chart
TheStreet Ratings Grade for SGEN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 4 4 4 3
Moderate Buy 0 0 0 0
Hold 3 3 2 4
Moderate Sell 0 0 0 0
Strong Sell 2 2 2 2
Mean Rec. 2.56 2.56 2.50 2.78
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: -68.58
Price Earnings Comparisons:
SGEN Sector Avg. S&P 500
-68.58 0.00 28.91
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-0.78% -14.94% 113.35%
GROWTH 12 Mo 3 Yr CAGR
Revenue 27.70 1.51 0.35
Net Income 0.00 -0.06 0.00
EPS 0.00 -0.23 0.00
Earnings for SGEN:
EBITDA -0.05B
Revenue 0.27B
Average Earnings Estimates
Qtr (09/14) Qtr (12/14) FY (12/14) FY (12/15)
Average Estimate $-0.25 $-0.29 $-0.82 $-0.63
Number of Analysts 8 7 9 9
High Estimate $-0.15 $-0.26 $-0.70 $-0.26
Low Estimate $-0.30 $-0.36 $-0.95 $-1.03
Prior Year $-0.19 $-0.13 $-0.51 $-0.82
Growth Rate (Year over Year) -32.24% -121.98% -59.91% 22.62%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
A HERO may still emerge.
Become more aggressive about the real valuations of companies.
The $193 level on the SPY will be key today.
Thursday's SPY trade plan will involve fading the edges,
You're looking at one.
Bullish
May 06, 2014 | 7:19 AM EDT
SGEN was upgraded to Neutral, Bank of America/Merrill Lynch said. Valuation call, based on a $40 price target. 
For these kinds of growth stocks, you have no choice but to wait.
Here are some specific stocks working as parables right now.
It's sardonic, corroded commentary designed to keep your pole in the boat.

Columnist Conversations

Lang:
Much of the run higher in gold over the last several years has been born of the skepticism over the Fed's gran...
CBI touched a 2014 peak of $89.22 and was much loved. Today it broke below $60 and nobody seems interested in ...
Many people had been complaining that there were not many stock market bargains to be had last week. When they...
NFLX is trading $440.66, down 3.7% with IV30™ up 22.3%. Conclusion I have written about NFLX extensivel...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.